Cargando…

Tumor Cell-Intrinsic BTLA Receptor Inhibits the Proliferation of Tumor Cells via ERK1/2

B and T lymphocyte attenuator (BTLA) is an immune checkpoint molecule that mediates the escape of tumor cells from immunosurveillance. Consequently, BTLA and its ligand herpesvirus entry mediator (HVEM) are potentially immunotherapeutic targets. However, the potential effects of BTLA on tumor cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Tian-You, Liu, Ya-Juan, Yan, Hong, Xi, Yi-Bo, Duan, Li-Qiang, Wang, Yang, Zhang, Tian-Tian, Gu, Yin-Min, Wang, Xiao-Dong, Wu, Chang-Xin, Gao, Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777428/ https://www.ncbi.nlm.nih.gov/pubmed/36552785 http://dx.doi.org/10.3390/cells11244021

Ejemplares similares

BTLA inhibition has a dominant role in the cis-complex of BTLA and HVEM
por: Battin, Claire, et al.
Publicado: (2022)

Uncovering a novel function of BTLA on tumor-infiltrating CD8+ T cells
por: Haymaker, Cara, et al.
Publicado: (2013)

Association of BTLA Polymorphisms with Susceptibility to Non-Small-Cell Lung Cancer in the Chinese Population
por: Wang, Jusi, et al.
Publicado: (2021)

Dual inhibition of BTLA and PD-1 can enhance therapeutic efficacy of paclitaxel on intraperitoneally disseminated tumors
por: Sun, Wei-Zen, et al.
Publicado: (2023)

Clinical significance of tumor‐infiltrating immune cells focusing on BTLA and Cbl‐b in patients with gallbladder cancer
por: Oguro, Seiji, et al.
Publicado: (2015)

Downregulation of BTLA on NKT Cells Promotes Tumor Immune Control in a Mouse Model of Mammary Carcinoma
por: Sekar, Divya, et al.
Publicado: (2018)

BTLA, a key regulator of Vγ9Vδ2 T-cell proliferation
por: Gertner-Dardenne, Julie, et al.
Publicado: (2013)

BTLA Expression and Function Are Impaired on SLE B Cells
por: Wiedemann, Annika, et al.
Publicado: (2021)

The Methylation in B7-H4 and BTLA Genes are Associated with the Risk of Pulmonary Tuberculosis
por: Cai, Xue-Qian, et al.
Publicado: (2023)

BTLA marks a less-differentiated tumor-infiltrating lymphocyte subset in melanoma with enhanced survival properties
por: Haymaker, Cara L, et al.
Publicado: (2015)

Dexamethasone inhibits the proliferation of tumor cells
por: Wu, Yuantao, et al.
Publicado: (2019)

Modification of BTLA signaling motifs in TIL exhibits positive signals that mediate anti-tumor control
por: Ritthipichai, Krit, et al.
Publicado: (2015)

Roles of BTLA in Immunity and Immune Disorders
por: Ning, Zhaochen, et al.
Publicado: (2021)

BTLA Expression in CLL: Epigenetic Regulation and Impact on CLL B Cell Proliferation and Ability to IL-4 Production
por: Karabon, Lidia, et al.
Publicado: (2021)

The BTLA and PD‐1 signaling pathways independently regulate the proliferation and cytotoxicity of human peripheral blood γδ T cells
por: Hwang, Hyun J., et al.
Publicado: (2020)

Pirfenidone decreases mesothelioma cell proliferation and migration via inhibition of ERK and AKT and regulates mesothelioma tumor microenvironment in vivo
por: Li, Chang, et al.
Publicado: (2018)

Verteporfin inhibits papillary thyroid cancer cells proliferation and cell cycle through ERK1/2 signaling pathway
por: Liao, Tian, et al.
Publicado: (2018)

Tumor cells with KRAS or BRAF mutations or ERK5/MAPK7 amplification are not addicted to ERK5 activity for cell proliferation
por: Lochhead, Pamela A., et al.
Publicado: (2016)

TMPRSS4 Promotes Cell Proliferation and Inhibits Apoptosis in Pancreatic Ductal Adenocarcinoma by Activating ERK1/2 Signaling Pathway
por: Gu, Jianyou, et al.
Publicado: (2021)

PCSK9 promotes tumor cell proliferation and migration by facilitating CCL25 secretion in esophageal squamous cell carcinoma
por: Wang, Haijun, et al.
Publicado: (2023)

Mitochondrial ferritin, a new target for inhibiting neuronal tumor cell proliferation
por: Shi, Zhen-Hua, et al.
Publicado: (2014)

Curcumin inhibits adverse psychological stress‐induced proliferation and invasion of glioma cells via down‐regulating the ERK/MAPK pathway
por: Wang, Ping, et al.
Publicado: (2021)

TAK1 Phosphorylates RASSF9 and Inhibits Esophageal Squamous Tumor Cell Proliferation by Targeting the RAS/MEK/ERK Axis
por: Shi, Hui, et al.
Publicado: (2021)

Tunicamycin inhibits cell proliferation and migration in hepatocellular carcinoma through suppression of CD44s and the ERK1/2 pathway
por: Hou, Helei, et al.
Publicado: (2018)

Artesunate, as an Hsp90 inhibitor, inhibits the proliferation of Burkitt’s lymphoma cells by inhibiting AKT and ERK
por: Yuan-Ce, Li, et al.
Publicado: (2023)

BTLA as a biomarker and mediator of sepsis-induced immunosuppression
por: Sherwood, Edward R, et al.
Publicado: (2013)

Disulfide-Linked Peptides for Blocking BTLA/HVEM Binding
por: Spodzieja, Marta, et al.
Publicado: (2020)

ERK inhibition represses gefitinib resistance in non-small cell lung cancer cells
por: Qi, Mengfan, et al.
Publicado: (2018)

PDGFR kinase inhibitor protects against septic death via regulation of BTLA
por: Wang, Qiang, et al.
Publicado: (2022)

Sorafenib inhibits ovarian cancer cell proliferation and mobility and induces radiosensitivity by targeting the tumor cell epithelial–mesenchymal transition
por: Tian, Chuntao, et al.
Publicado: (2022)

The Expression of LIGHT Was Increased and the Expression of HVEM and BTLA Were Decreased in the T Cells of Patients with Rheumatoid Arthritis
por: Yang, Bin, et al.
Publicado: (2016)

A novel c-Met/TRK inhibitor 1D228 efficiently inhibits tumor growth by targeting angiogenesis and tumor cell proliferation
por: An, Baijiao, et al.
Publicado: (2023)

NEAT1 Negatively Regulates Cell Proliferation and Migration of Neuroblastoma Cells by miR-183-5p/FOXP1 Via the ERK/AKT Pathway
por: Pan, Weikang, et al.
Publicado: (2020)

HMGB1 released by irradiated tumor cells promotes living tumor cell proliferation via paracrine effect
por: He, Sijia, et al.
Publicado: (2018)

PD-1 and BTLA and CD8(+) T-cell “exhaustion” in cancer: “Exercising” an alternative viewpoint
por: Haymaker, Cara, et al.
Publicado: (2012)

Design of short peptides to block BTLA/HVEM interactions for promoting anticancer T-cell responses
por: Spodzieja, Marta, et al.
Publicado: (2017)

Association between BTLA polymorphisms and susceptibility to esophageal squamous cell carcinoma in the Chinese population
por: Cao, Rui, et al.
Publicado: (2020)

The Co-inhibitor BTLA Is Functional in ANCA-Associated Vasculitis and Suppresses Th17 Cells
por: Werner, Kai, et al.
Publicado: (2019)

High BTLA Expression Likely Contributes to Contraction of the Regulatory T Cell Subset in Lupus Disease
por: Aubergeon, Lucie, et al.
Publicado: (2021)

NGF increases VEGF expression and promotes cell proliferation via ERK1/2 and AKT signaling in Müller cells
por: Wang, Jing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b6slao5a7j4gv19d6t9vi0ua0u